About the Company
rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $RIGL News
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the appointment of Lisa Rojkjaer, M.D. as Executive Vice President ...
Owning 47% shares,institutional owners seem interested in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL),
Key Insights Significantly high institutional ownership implies Rigel Pharmaceuticals' stock price is sensitive ...
RIGL Stock Earnings: Rigel Pharmaceuticals Beats Revenue for Q4 2023
Stock Market News, Stock Advice & Trading Tips Rigel Pharmaceuticals (NASDAQ:RIGL) just reported results for the fourth ...
Rigel Pharmaceuticals GAAP EPS of $0.00 beats by $0.02, revenue of $35.8M beats by $2.39M
Q4 GAAP EPS of $0.00 beats by $0.02. Revenue of $35.8M (-30.2% Y/Y) beats by $2.39M. Fourth quarter 2023 Total Revenue of ...
Rigel Pharmaceuticals files patent for pyrazole compound for inhibiting IRAK protein in subjects
Discover the groundbreaking patent by Rigel Pharmaceuticals for a compound targeting IRAK proteins to treat a wide range of diseases. Learn more about its potential in autoimmune, inflammatory, ...
Rigel Pharmaceuticals, Inc. (RIGL) Q4 2023 Earnings Call Transcript
Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Full Year 2023. At this time, all participants are in a listen-only mode. A brief question-and ...
Rigel Pharma Names Rojkjaer EVP, Chief Medical Officer
(RTTNews) - Tuesday, Rigel Pharmaceuticals, Inc. (RIGL) appointed Lisa Rojkjaer, as executive vice president and chief medical officer. Rojkjaer, a board-certified hematologist with an ...
Rigel Pharmaceuticals names new Chief Medical Officer
SOUTH SAN FRANCISCO, Calif. - Rigel (NASDAQ:RIGL) Pharmaceuticals, Inc. (NASDAQ:RIGL) has announced the appointment of Lisa Rojkjaer, M.D., as its new Executive Vice President and Chief Medical ...
Rigel Pharmaceuticals: Q4 Earnings Insights
Rigel Pharmaceuticals RIGL reported its Q4 earnings results on Tuesday, March 5, 2024 at 04:01 PM. Here's what investors need to know about the announcement. Rigel Pharmaceuticals beat estimated ...
Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
SOUTH SAN FRANCISCO, Calif., March 12, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the appointment of Lisa Rojkjaer, M.D. as Executive Vice President and Chief ...
Rigel Pharmaceuticals, Inc.: Rigel Pharmaceuticals Announces Appointment of Lisa Rojkjaer, M.D. as Chief Medical Officer
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the appointment of Lisa Rojkjaer, M.D. as Executive Vice President and Chief ...
Loading the latest forecasts...